Evidence map›Paper›PMID 29576945›Full record

ArticlePeerJ2018

Establishment and quality evaluation of a glioma biobank in Beijing Tiantan Hospital.

Fanhong Kong, Wenli Zhang, Lin Qiao, Qi Li, Haowen Li, Jingli Cao, Wenyan He, Chengya Dong, Yanjiao He, Lu He and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fanhong Kong *Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wenli Zhang *Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Lin QiaoClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Qi LiClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Haowen LiClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jingli CaoClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wenyan HeClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Chengya DongClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yanjiao HeNeuropathological department, Beijing Neurosugical Institute, Capital Medical University, Beijing, China.
Lu HeBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Li LiuClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Weilun FuBeijing Tiantan Hospital, Capital Medical University, Beijing, China.
Lijun LiuDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Zirui LiClinical Medical Research Laboratory, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yajie WangClinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe established a glioma biobank at Beijing Tiantan Hospital in November, 2010. Specialized residents have been trained to collect, store and manage the biobank in accordance with standard operating procedures.

methodsOne hundred samples were selected to evaluate the quality of glioma samples stored in the liquid nitrogen tank during different periods (from 2011 to 2015) by morphological examination, RNA integrity determination, DNA integrity determination and housekeeping gene expression determination.

resultsThe majority of samples (95%) had high RNA quality for further analysis with RIN ≥6. Quality of DNA of all samples were stable without significant degradation.

conclusionStorage conditions of our biobank are suitable for long-term (at least five years) sample preservation with high molecular quality.

Indexed as

BiobankGliomaQuality evaluation

Identifiers

PMID29576945
PMCPMC5855883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.